Skip to main content
. 2016 Apr 4;113(16):4476–4481. doi: 10.1073/pnas.1525360113

Fig. S10.

Fig. S10.

Treatment with B20 or A2V does not affect the presence of MDSCs in Gl261 or MGG8 tumors as compared with IgG treatment. In all Gl261 panels, IgG, n = 6; B20, n = 6; A2V, n = 5. (A and B) MDSCs were defined as CD45+/CD11bpos/GR1+/CD11b+. (C) No changes in MDSC presence were seen in Gl261 tumors. In all MGG8 panels, IgG, n = 4; B20, n = 7; A2V, n = 9. (D and E) Representative MDSC gates in the MGG8 tumor model. (F) The presence of MDSCs was not changed by treatment in the MGG8 model.